TrialThe Journal of investigative dermatology2017

Inhibition of β-Catenin Signaling in the Skin Rescues Cutaneous Adipogenesis in Systemic Sclerosis: A Randomized, Double-Blind, Placebo-Controlled Trial of C-82.

Robert Lafyatis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.